Q4 2020 13F Holders as of 31 Dec 2020
-
Type / Class
-
Equity / COM
-
Number of holders
-
15
-
Total 13F shares, excl. options
-
111,845
-
Shares change
-
+111,568
-
Total reported value, excl. options
-
$4,075,294
-
Value change
-
+$4,065,221
-
Number of buys
-
15
-
Price
-
$36.46
Significant Holders of Greenwich LifeSciences, Inc. - COM (GLSI) as of Q4 2020
15 filings reported holding GLSI - Greenwich LifeSciences, Inc. - COM as of Q4 2020.
Greenwich LifeSciences, Inc. - COM (GLSI) has 15 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 111,845 shares
.
Largest 10 shareholders include BlackRock Inc. (59,296 shares), VANGUARD GROUP INC (11,309 shares), SkyOak Wealth, LLC (8,104 shares), MILLENNIUM MANAGEMENT LLC (7,212 shares), Creative Planning (7,043 shares), GEODE CAPITAL MANAGEMENT, LLC (7,020 shares), MORGAN STANLEY (3,803 shares), BANK OF MONTREAL /CAN/ (3,000 shares), BANK OF AMERICA CORP /DE/ (2,097 shares), and WELLS FARGO & COMPANY/MN (1,125 shares).
This table shows the top 15 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.